Paper Details 
Original Abstract of the Article :
Etodolac, a highly lipophilic anti-inflammatory drug, is widely used in rheumatoid arthritis usually at an oral dose of 200 mg twice daily. The commonest side effects during therapy with etodolac is generally gastrointestinal disturbances these are usually mild and reversible but in some patients ar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/10717540701603746

データ提供:米国国立医学図書館(NLM)

Improving Etodolac Delivery for Rheumatoid Arthritis

Etodolac, a commonly used anti-inflammatory drug, is often taken orally to treat rheumatoid arthritis, but it can cause stomach upset. This study explores using a topical gel formulation of etodolac to deliver the drug directly to the skin, minimizing the risk of gastrointestinal side effects. The researchers investigate different terpenes as enhancers for skin penetration.

Hydrophilic Gels Enhance Etodolac Delivery

The study found that hydrophilic gels containing anethole, a hydrophobic terpene, significantly improved the percutaneous absorption of etodolac. This suggests that topical gel formulations could offer an effective alternative to oral administration, potentially reducing gastrointestinal side effects.

A Promising Topical Approach to Rheumatoid Arthritis Treatment

This research offers a potential solution to the gastrointestinal side effects associated with oral etodolac. The study’s findings support the development of topical formulations as a safer and more effective way to deliver this important anti-inflammatory drug.

Dr. Camel's Conclusion

This study is like finding a cool spring oasis in the hot desert of gastrointestinal side effects. The findings suggest that topical etodolac gel formulations could offer a more comfortable and effective way to manage rheumatoid arthritis, minimizing the risk of digestive discomfort. This approach has the potential to improve the quality of life for patients living with this debilitating disease.

Date :
  1. Date Completed 2007-12-18
  2. Date Revised 2019-05-16
Further Info :

Pubmed ID

17994363

DOI: Digital Object Identifier

10.1080/10717540701603746

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.